跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DEXTROSE 50% - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DEXTROSE 50%
Authorized
STANDARD
DEXTROSE 50%
Valesco Pharmaceuticals Inc
🇨🇦 Health Canada
Approval Date
Feb 6, 2026
Approval ID
a61477ca6f15294f
Company
Valesco Pharmaceuticals Inc
Type
Standard
Approval Details
Approval Id
a61477ca6f15294f
Drug Approval Canada Name
DEXTROSE 50%
Product Name
DEXTROSE 50%
Status
Cancelled Post Market
Status Date
2018-09-05
Original Market Date
2011-10-26
Din
02350521
Drug Class
Veterinary
Dosage Form
Solution
Route Of Administration
Intraperitoneal , Intravenous
Schedule
NON-PRESCRIPTION DRUGS
Atc Original
Not Applicable
Aig Number
0102181001
Company Name
Valesco Pharmaceuticals Inc
Company Address
3592 Boul. Poirier Saint-Laurent Quebec Canada H4R 2J5
Company Detail Path
/organization/valesco-pharmaceuticals-inc
Company Information
Pharmaceutical Company Name
Valesco Pharmaceuticals Inc
Country Name
Canada
Province Name
Quebec
City Name
saint-laurent,quebec,country_ca
Address
3606 boul Poirier
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 6, 2026
Approval ID
a61477ca6f15294f
Type
Standard
Back to Health Canada Approvals